Harlequim

Harlequim is a CBD-forward hybrid built for therapeutic use rather than a psychoactive high. Lab-tested phenotypes typically show very low THC (about 0–1%) alongside elevated CBD in the 8–15% range, so users commonly report clear-headed relief instead of strong intoxication. Its aroma and flavor lean earthy and mild with subtle fruity and spicy notes, making it pleasant for both vaping and smoking or for creating oils and tinctures. On the effects side, Harlequim is valued for symptom relief: many people use it to manage pain, inflammation, anxiety, and some seizure disorders because the cannabinoid profile emphasizes CBD over THC. Expect a gentle, body-oriented calm with mental clarity rather than sedation or euphoria; subjective effects will vary by phenotype and dose. That moderate, non-intoxicating profile also makes Harlequim a solid option for daytime therapeutic use. For growers, Harlequim behaves like a fairly standard hybrid: flowering runs about 8–9 weeks under typical conditions. Plants are generally stable and can perform well indoors or outdoors with attentive care; resistance to common pests and stresses is reasonable but not exceptional, so basic integrated pest management and proper environmental control pay off. Because it’s a feminized variety, seeds are intended to produce mostly female plants, simplifying a medicinal grower’s workflow.